Effect of acetaminophen in patent ductus arteriosus
Phase 2
Recruiting
- Conditions
- Patent ductus arteriosus.Other congenital malformations of cardiac chambers and connectionsQ20.8
- Registration Number
- IRCT20200218046538N1
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
All of preterm neonat
Gestational ??? less than 32 week
Weight less than 1500 gram
Exclusion Criteria
Congenital heart disease
Major congenital anomaly
Use of NSAID in pregnancy with mother
Persistant pulmonary hypertention
APGAR scor less than 5
Vomitting or hematemesis
G6PD deficency
Sepsis
Intra ventricular hemorrage
Urin out put less than 1 cc/kg/hr
Cr more than 1/8 mg/dl
Plt less than 50000
NEC
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patent ductus arteriosus closure in preterm infants. Timepoint: Percentage of patent ductus arteriosus closure in preterm infants on fifth day of birth. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method